| Product Code: ETC13279945 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Enteric Disease Market was valued at USD 4.2 Billion in 2024 and is expected to reach USD 6.8 Billion by 2031, growing at a compound annual growth rate of 7.90% during the forecast period (2025-2031).
The Global Enteric Disease Market encompasses various infectious diseases affecting the gastrointestinal tract, primarily caused by bacteria, viruses, and parasites. This market includes diagnostics, therapeutics, and vaccines aimed at preventing and treating conditions such as diarrhea, cholera, typhoid fever, and other related illnesses. The market is driven by increasing incidences of enteric diseases, particularly in developing regions with poor sanitation and hygiene practices. Key players in this market are focusing on developing innovative diagnostic tools for early detection, as well as effective treatments and vaccines to reduce the burden of enteric diseases globally. Government initiatives, public awareness campaigns, and collaborations between healthcare organizations and research institutions are also contributing to the growth of the Global Enteric Disease Market.
The Global Enteric Disease Market is experiencing significant growth driven by the increasing prevalence of enteric diseases such as diarrheal diseases, typhoid fever, and cholera. The market is witnessing a rise in demand for diagnostic tests, vaccines, and treatment options to combat these diseases effectively. Key opportunities in the market include the development of advanced diagnostic technologies for early detection, the introduction of novel vaccines for prevention, and the expansion of healthcare infrastructure in emerging markets. Additionally, the growing awareness about sanitation and hygiene practices is expected to drive market growth further. Companies operating in this market have the potential to capitalize on these trends by investing in research and development to bring innovative solutions to the market and expand their global footprint.
The Global Enteric Disease Market faces several challenges, including limited access to clean water and sanitation in developing countries, which contributes to the high prevalence of enteric diseases such as cholera and typhoid. Additionally, inadequate healthcare infrastructure and lack of awareness about preventive measures pose obstacles to effective disease management and control. The emergence of drug-resistant strains of bacteria further complicates treatment options, leading to higher healthcare costs and increased burden on healthcare systems. Moreover, the lack of investment in research and development for enteric diseases compared to other infectious diseases hinders the development of new therapies and diagnostics. Addressing these challenges will require collaborative efforts from governments, healthcare providers, and pharmaceutical companies to improve sanitation, increase access to healthcare services, and develop innovative solutions for enteric disease prevention and treatment.
The Global Enteric Disease Market is primarily driven by factors such as the increasing prevalence of enteric diseases, growing awareness about the importance of hygiene and sanitation, and the rising demand for rapid diagnostic tests and effective treatment options. Additionally, the implementation of vaccination programs, advancements in healthcare infrastructure, and the focus on preventive measures by governments and healthcare organizations are also key drivers for market growth. The emergence of innovative technologies for diagnosis and treatment, along with the rising investments in research and development activities, further contribute to the expansion of the enteric disease market. Overall, the increasing emphasis on disease prevention, early detection, and effective management of enteric diseases is propelling the market forward.
Government policies related to the Global Enteric Disease Market mainly focus on prevention, surveillance, and control measures to reduce the burden of enteric diseases such as cholera, typhoid, and diarrheal illnesses. Governments worldwide have implemented vaccination programs, water sanitation initiatives, and hygiene education campaigns to prevent the spread of enteric diseases. Additionally, regulatory bodies have established guidelines for the development and approval of enteric disease treatments and diagnostics to ensure their safety and efficacy. Government funding and support for research and development in this sector are also crucial in advancing innovative solutions for enteric disease prevention and management. Overall, government policies play a significant role in shaping the landscape of the Global Enteric Disease Market by addressing public health challenges and promoting sustainable solutions to combat these infectious diseases.
The Global Enteric Disease Market is expected to witness significant growth in the coming years, driven by factors such as increasing incidence of enteric diseases, rising awareness about sanitation and hygiene practices, and advancements in diagnostic technologies. The market is projected to expand as governments and healthcare organizations focus on implementing preventive measures and improving healthcare infrastructure to tackle enteric diseases. Additionally, the growing demand for effective treatment options and the development of novel therapeutics and vaccines are likely to further propel market growth. However, challenges such as limited access to healthcare in developing regions and the emergence of drug-resistant strains may hinder market growth to some extent. Overall, the Global Enteric Disease Market is anticipated to show promising opportunities for market players and stakeholders in the near future.
In the Global Enteric Disease Market, Asia is expected to witness significant growth due to increasing investments in healthcare infrastructure and rising awareness about enteric diseases. North America and Europe are projected to dominate the market, driven by advanced healthcare facilities and high adoption of innovative diagnostic and treatment solutions. The Middle East and Africa region is anticipated to experience moderate growth due to improving healthcare services and rising prevalence of enteric diseases. Latin America is also expected to show steady growth, supported by increasing government initiatives for disease prevention and control. Overall, the global enteric disease market is forecasted to expand across all regions, with varying degrees of growth influenced by factors such as healthcare investments, disease prevalence, and regulatory environment.
Global Enteric Disease Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Enteric Disease Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Enteric Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Global Enteric Disease Market - Industry Life Cycle |
3.4 Global Enteric Disease Market - Porter's Five Forces |
3.5 Global Enteric Disease Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Enteric Disease Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.7 Global Enteric Disease Market Revenues & Volume Share, By Testing Method, 2021 & 2031F |
3.8 Global Enteric Disease Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Global Enteric Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Enteric Disease Market Trends |
6 Global Enteric Disease Market, 2021 - 2031 |
6.1 Global Enteric Disease Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Enteric Disease Market, Revenues & Volume, By Bacterial Enteric Disease, 2021 - 2031 |
6.1.3 Global Enteric Disease Market, Revenues & Volume, By C.difficile Infection, 2021 - 2031 |
6.1.4 Global Enteric Disease Market, Revenues & Volume, By Cholera, 2021 - 2031 |
6.1.5 Global Enteric Disease Market, Revenues & Volume, By E.coli Infection, 2021 - 2031 |
6.1.6 Global Enteric Disease Market, Revenues & Volume, By Viral Enteric Disease, 2021 - 2031 |
6.1.7 Global Enteric Disease Market, Revenues & Volume, By Rotavirus Infection, 2021 - 2031 |
6.1.8 Global Enteric Disease Market, Revenues & Volume, By Noravirus Infection, 2021 - 2031 |
6.1.9 Global Enteric Disease Market, Revenues & Volume, By Parasitic Enteric Disease, 2021 - 2031 |
6.2 Global Enteric Disease Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Enteric Disease Market, Revenues & Volume, By Immunoassay Testing, 2021 - 2031 |
6.2.3 Global Enteric Disease Market, Revenues & Volume, By Conventional Testing, 2021 - 2031 |
6.2.4 Global Enteric Disease Market, Revenues & Volume, By Molecular Diagnostic Testing, 2021 - 2031 |
6.3 Global Enteric Disease Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Enteric Disease Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 Global Enteric Disease Market, Revenues & Volume, By Diagnostic Laboratories, 2021 - 2031 |
6.3.4 Global Enteric Disease Market, Revenues & Volume, By Physician Offices, 2021 - 2031 |
7 North America Enteric Disease Market, Overview & Analysis |
7.1 North America Enteric Disease Market Revenues & Volume, 2021 - 2031 |
7.2 North America Enteric Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Enteric Disease Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Enteric Disease Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Enteric Disease Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Enteric Disease Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.4 North America Enteric Disease Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
7.5 North America Enteric Disease Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Latin America (LATAM) Enteric Disease Market, Overview & Analysis |
8.1 Latin America (LATAM) Enteric Disease Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Enteric Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Enteric Disease Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Enteric Disease Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Enteric Disease Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Enteric Disease Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Enteric Disease Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
8.4 Latin America (LATAM) Enteric Disease Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
8.5 Latin America (LATAM) Enteric Disease Market, Revenues & Volume, By End User, 2021 - 2031 |
9 Asia Enteric Disease Market, Overview & Analysis |
9.1 Asia Enteric Disease Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Enteric Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Enteric Disease Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Enteric Disease Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Enteric Disease Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Enteric Disease Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Enteric Disease Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
9.4 Asia Enteric Disease Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
9.5 Asia Enteric Disease Market, Revenues & Volume, By End User, 2021 - 2031 |
10 Africa Enteric Disease Market, Overview & Analysis |
10.1 Africa Enteric Disease Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Enteric Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Enteric Disease Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Enteric Disease Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Enteric Disease Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Enteric Disease Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Enteric Disease Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
10.4 Africa Enteric Disease Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
10.5 Africa Enteric Disease Market, Revenues & Volume, By End User, 2021 - 2031 |
11 Europe Enteric Disease Market, Overview & Analysis |
11.1 Europe Enteric Disease Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Enteric Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Enteric Disease Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Enteric Disease Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Enteric Disease Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Enteric Disease Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Enteric Disease Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
11.4 Europe Enteric Disease Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
11.5 Europe Enteric Disease Market, Revenues & Volume, By End User, 2021 - 2031 |
12 Middle East Enteric Disease Market, Overview & Analysis |
12.1 Middle East Enteric Disease Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Enteric Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Enteric Disease Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Enteric Disease Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Enteric Disease Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Enteric Disease Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
12.4 Middle East Enteric Disease Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
12.5 Middle East Enteric Disease Market, Revenues & Volume, By End User, 2021 - 2031 |
13 Global Enteric Disease Market Key Performance Indicators |
14 Global Enteric Disease Market - Export/Import By Countries Assessment |
15 Global Enteric Disease Market - Opportunity Assessment |
15.1 Global Enteric Disease Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Enteric Disease Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
15.3 Global Enteric Disease Market Opportunity Assessment, By Testing Method, 2021 & 2031F |
15.4 Global Enteric Disease Market Opportunity Assessment, By End User, 2021 & 2031F |
16 Global Enteric Disease Market - Competitive Landscape |
16.1 Global Enteric Disease Market Revenue Share, By Companies, 2024 |
16.2 Global Enteric Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |